About: Koen Van Laere

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Koen Van Laere Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) araştırmacı (tr) wetenschapper (nl) дослідник (uk) изилдөөчү (ky) 研究者 (zh)
rdfs:label	Koen Van Laere (en) Koen Van Laere (nl)
skos:prefLabel	Koen Van Laere (en) Koen Van Laere (nl)
name	Koen Van Laere (en) Koen Van Laere (nl)
given name	wds:Q88381272-5bc40aef-4fe0-2d4f-474a-26baaad53df3
given name	Koen
instance of	wds:Q88381272-F99AC98A-E445-4979-A49C-A84DB34263FC
instance of	Homo sapiens
occupation	wds:Q88381272-C356F731-1795-4E34-A7C5-BB4F32FAF195
on focus list of Wikimedia project	wds:Q88381272-F2033A96-4373-4C06-AC91-D2FF43DF10B5
occupation	researcher
on focus list of Wikimedia project	WikiProject COVID-19
ORCID iD	wds:Q88381272-44BB3617-DB22-470B-A46C-B2CD619EFF3C
ORCID iD	https://orcid.org/0000-0001-5200-7245
ORCID iD	0000-0001-5200-7245
IEEE Xplore author ID	wds:Q88381272-EB37573B-BAA4-4E9D-8416-90EDDD6323E7
IEEE Xplore author ID	37332588800
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q88381272
is author of	Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model. Visualizing out-of-body experience in the brain Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial A European multicentre PET study of fibrillar amyloid in Alzheimer's disease Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa. The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake Abeta amyloid deposition in the language system and how the brain responds No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease Measuring extrastriatal dopamine release during a reward learning task Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis Automated quantitative gait analysis in animal models of movement disorders Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. 3D Shape Perception in Posterior Cortical Atrophy: A Visual Neuroscience Perspective Neurological picture. FDG-PET findings in three cases of Mills' syndrome The use of SPECT and PET in routine clinical practice in epilepsy [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers Construction and evaluation of quantitative small-animal PET probabilistic atlases for [¹⁸F]FDG and [¹⁸F]FECT functional mapping of the mouse brain Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament. Neurostimulation for refractory epilepsy In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. Optimization of multimodal imaging of mesenchymal stem cells using the human sodium iodide symporter for PET and Cerenkov luminescence imaging. Motor- and food-related metabolic cerebral changes in the activity-based rat model for anorexia nervosa: a voxel-based microPET study. Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470. Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human New transient receptor potential vanilloid subfamily member 1 positron emission tomography radioligands: synthesis, radiolabeling, and preclinical evaluation. The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease. Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease Micro-positron emission tomography imaging of rat brain metabolism during expression of contextual conditioning. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. Autoimmune-mediated encephalitis. Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5. Neuronuclear assessment of patients with epilepsy. Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia In vivo evidence for long-term vascular remodeling resulting from chronic cerebral hypoperfusion in mice.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software